Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,045
Closed -$230K 123
2025
Q3
$230K Buy
9,045
+375
+4% +$9.26K 0.05% 92
2025
Q2
$210K Sell
8,670
-381
-4% -$8.88K 0.05% 94
2025
Q1
$229K Sell
9,051
-3,590
-28% -$93.9K 0.06% 95
2024
Q4
$335K Buy
12,641
+3,547
+39% +$96.2K 0.08% 69
2024
Q3
$263K Sell
9,094
-3,192
-26% -$93.1K 0.06% 85
2024
Q2
$344K Sell
12,286
-8,180
-40% -$225K 0.09% 67
2024
Q1
$568K Sell
20,466
-227,193
-92% -$6.3M 0.18% 54
2023
Q4
$7.13M Buy
+247,659
New +$7.49M 2.24% 15
2021
Q3
Sell
-7,063
Closed -$277K 50
2021
Q2
$277K Sell
7,063
-98,706
-93% -$3.84M 0.13% 45
2021
Q1
$3.83M Sell
105,769
-36,868
-26% -$1.31M 1.86% 18
2020
Q4
$5.25M Sell
142,637
-5,149
-3% -$189K 2.69% 16
2020
Q3
$5.15M Buy
147,786
+2,453
+2% +$86K 2.88% 13
2020
Q2
$4.51M Buy
145,333
+2,273
+2% +$77.2K 2.69% 16
2020
Q1
$4.43M Buy
143,060
+42,136
+42% +$1.44M 3.31% 13
2019
Q4
$3.75M Buy
+100,924
New +$3.59M 2.54% 17
2019
Q1
Sell
-4,898
Closed -$203K 52
2018
Q4
$203K Buy
+4,898
New +$203K 0.2% 49

Other funds holding PFE

Hamilton Wealth's PFE Position: Q4 2025 in Review

Hamilton Wealth sold out of Pfizer (PFE) in Q4 2025, closing a stake of 9,045 shares — an estimated $230K sold.

Hamilton Wealth first reported a position in PFE in Q4 2018 and held it in 16 quarters. The position peaked at $7.13M in Q4 2023. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Hamilton Wealth reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Hamilton Wealth sold 9,045 Pfizer shares in Q4 2025, an estimated $230K.
  • Hamilton Wealth first reported a position in Pfizer in Q4 2018 and held it in 16 quarters.
  • Hamilton Wealth's Pfizer position peaked at $7.13M in Q4 2023.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Hamilton Wealth's 13F filing for Q4 2025, filed 18 Feb 2026.